Planned
Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases (Trials4Health 2026)
The Research Council of Norway and the Regional Health Authorities jointly announce 1.2 million euros for transnational investigator-initiated clinical trials
The aim of the call is to support and enable transnational collaboration between clinical research communities on investigator-initiated clinical trials.
The studies for which funding is sought must:
- deal with cardiovascular, autoimmune or metabolic diseases
- be randomized
- be designed as pragmatic comparative-effictiveness studies and/or drug repuposing studies
If additional funding for cross-cutting management activities is to be applied for, ECRIN must be contacted by 30 November 2025.